TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD	Arterial Occlusive Diseases, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, vascular disorder	Recruiting	Phase 1 / Phase 2	2026-03-23		NCT07487363

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Hudson Biotech	8

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Peking University Shenzhen Hospital	Shenzhen	China	68

Clinical trials